Action Center

Deceptive Lawsuit Advertising
Action Alert
March 19, 2019

Likewise, House Bill 225, also sponsored by Rep. Kim Moser, will not be advancing this session. HB225 was designed to regulate advertising for legal services and protect patients from drug-injury advertisements on television, radio and social media. Specifically, the bill would have required advertisements to properly warn patients that it is dangerous to stop taking a prescribed medication before consulting with a physician; prohibited advertisements that solicit legal business from being mis-labeled as a “medical alert,” “health alert,” or “public service announcement;” protected personal health information from being used to solicit legal services without the prior consent of the patient; and prevented the use of governmental logos, such as the FDA’s, in a manner that suggests affiliation with that agency, or use of the word “recall” when a product has not been recalled. HB225 was supported by KMA and a wide variety of health care providers and patient advocates and will likely be seen again in 2020.

March 5, 2019

House Bill 225, sponsored by Rep. Kim Moser, received a hearing in the House Health and Family Services Committee last week. While the legislation was placed on the committee agenda for “discussion only” and did not receive a vote, the testimony by supporters, including KMA’s Secretary-Treasurer, Dr. Bob Couch, laid the groundwork for future action on the bill. HB225 is designed to regulate advertising for legal services and protect patients from drug-injury advertisements on television, radio and social media. Specifically, the bill would require advertisements to properly warn patients that it is dangerous to stop taking a prescribed medication before consulting with a physician; prohibit advertisements that solicit legal business from being mis-labeled as a “medical alert,” “health alert,” or “public service announcement;” protect personal health information from being used to solicit legal services without the prior consent of the patient; and prevent the use of governmental logos, such as the FDA’s, in a manner that suggests affiliation with that agency, or use of the word “recall” when a product has not been recalled. HB225 is supported by KMA and a wide variety of health care providers and patient advocates.

February 19, 2019

House Bill 225, sponsored by Rep. Kim Moser, is designed to regulate advertising for legal services and protect patients from drug-injury advertisements on television, radio and social media. Specifically, the bill would require advertisements to properly warn patients that it is dangerous to stop taking a prescribed medication before consulting with a physician; prohibit advertisements that solicit legal business from being mis-labeled as a “medical alert,” “health alert,” or “public service announcement;” protect personal health information from being used to solicit legal services without the prior consent of the patient; and prevent the use of governmental logos, such as the FDA’s, in a manner that suggests affiliation with that agency, or use of the word “recall” when a product has not been recalled. The bill is supported by KMA and a wide variety of health care providers and patient advocates.

Rep. Moser published an op-ed in the Louisville Courier-Journal last week discussing the bill. Members are encouraged to review and share the piece with colleagues and patients.

KMA anticipates that HB225 will be heard on Thursday by the House Health and Family Services Committee.

PLEASE CONTACT YOUR REPRESETNTATIVE
AND ASK THEM TO 
SUPPORT HOUSE BILL 225.


Legislative Message Line: (800) 372-7181
February 12, 2019

House Bill 225, sponsored by Rep. Kim Moser, is designed to regulate advertising for legal services and protect patients from drug-injury advertisements on television, radio and social media. Specifically, the bill would require advertisements to properly warn patients that it is dangerous to stop taking a prescribed medication before consulting with a physician; prohibit advertisements that solicit legal business from being mis-labeled as a “medical alert,” “health alert,” or “public service announcement;” protect personal health information from being used to solicit legal services without the prior consent of the patient; and prevent the use of governmental logos, such as the FDA’s, in a manner that suggests affiliation with that agency, or use of the word “recall” when a product has not been recalled. The bill is supported by KMA and a wide variety of health care providers and patient advocates. It has been referred to the House Health and Family Services Committee.
    Subject
    Message Body
    Tweet
    Suggested Message
    Post
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info